Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
نویسندگان
چکیده
620 Ann Dermatol Received September 19, 2014, Revised November 6, 2014, Accepted for publication November 12, 2014 Corresponding author: Sung Eun Chang, Department of Dermatology, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Tel: 82-2-3010-3460, Fax: 82-2-486-7831, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. REFERENCES
منابع مشابه
Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?
Adalimumab is a fully human monoclonal anti-tumor necrosis factor-a agent that is approved for the treatment of Crohn's disease. It has a good safety profile, injection site reactions being the most common adverse effect. We report a case of a 54-year-old woman with a 30-year history of Crohn's disease who developed achromic patches on the trunk and upper extremities after initiating treatment ...
متن کاملResponsivity to phototherapy in patients with vitiligo in Shahid Faghihi Hospital, Shiraz
Introduction: Psoralen plus ultraviolet A (PUVA), regardless of it's hazards to physician and patients, is considered to be treatment of choice for subtotal vitiligo. This study attempts to evaluate the efficacy of PUVA in treatment of patients with vitiligo. Methods: We have performed a descriptive-analytic study on 30 patients with vitiligo who received PUVA therapy during 2004-2005 in photo...
متن کاملErythema Nodosum During Adalimumab Therapy: An Idiopathic Transient Paradoxical Effect
Contrary to their undoubted efficacy on rheumatologic diseases, potential for developing skin lesions with Tumor necrosis alpha blockers (Anti-TNF alpha) is an important question in our minds. Although we know, most of the studies and case reports in the literature show that adalimumab is an effective treatment agent on erythema nodosum, we should keep in mind this lesion as a rare paradoxical ...
متن کاملTumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo
Tumour necrosis factor (TNF)-α, a proinflammatory cytokine central to many autoimmune diseases, has been implicated in the depigmentation process in vitiligo. We review its role in vitiligo by exploring its pro- and anti-inflammatory properties and examine the effects of blocking its actions with TNF-α antagonist therapeutics in reports available in the literature. We found that TNF-α inhibitio...
متن کاملA comparison between systemic PUVA therapy alone and combined with topical Calcipotriol in the treatment of generalized Vitiligo
Background: Vitiligo is a relatively common acquired depigmentary disorder affecting approximately 1% of general population. PUVA therapy is the most effective modality and commonly used as the primary treatment of generalized Vitiligo. Objective: To evaluate the synergistic effect of topical Calcipotriol and oral methoxalene plus PUVA in treatment of generalized Vitiligo. Patients and Me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 27 شماره
صفحات -
تاریخ انتشار 2015